Probe of AstraZeneca executive in China raises questions about company’s tactics

Taking stock of the drug industry, from the lab to the medicine chest

November 4, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

ANDREW YATES/AFP via Getty Images STAT+ | Probe of AstraZeneca executive in China raises questions about company's tactics The announcement of the investigation of Leon Wang followed the recent detention of Eva Yin, a former AstraZeneca executive in China. By Brian Yang What really happens to drug prices when patents expire STAT's 'Behind The Counter,' a video series that demystifies the tangled web of prescription drug prices and patent law, examines patent thickets. By Anna Yeo Opinion: How to bring more Black Americans into clinical research: Address the root causes of medical skepticism On the same ground as the infamous Tuskegee experiment, we are working to overcome medical racism and bring more Black Americans into clinical research. By Khalilah Brown and Stephen Sodeke Photo illustration: Christine Kao/STAT; Photos: Francesca Jones, Brian L. Frank, Kevin Patrick STAT+ | These 7 watchdogs scour scientific papers for problems — and often find them STAT's Who to Know series, which profiles movers and shakers in the life sciences, profiles scientific sleuths looking for research fraud By Jonathan Wosen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser